Entourage Health Announces Preliminary Fiscal Year 2021 Record Revenue of $54.8 Million with Q4 and Full-Year 2021 Financials to be filed by April 1, 2022
11 févr. 2022 07h30 HE
|
Entourage Health Corp.
FYE 2021 revenues up 54% over prior year due to record sales and expanded market share(1)Conference call to review financial results to be held on April 1, 2022 at 10 a.m. Eastern time Company also...
Entourage Health Reports Q3 Financial Results with $14.9 Million Record Revenue Representing 94% YOY Increase and Fourth Consecutive Quarter of Growth
16 nov. 2021 07h00 HE
|
Entourage Health Corp.
Adult-Use net revenue for the quarter increased by 102% compared to last yearSales, general and administrative costs decreased by 16% compared to last yearStrategic acquisition of craft cultivator...
Entourage Health Announces Preliminary Q3 Record Revenue of $14.7 Million and Confirms Financial Results Call to be Held on November 16, 2021 at 10 a.m. ET
19 oct. 2021 08h36 HE
|
Entourage Health Corp.
Fourth consecutive quarter of growth attributed to expanding market share and record salesCompany also completes amendments to its $39 million senior secured credit facility TORONTO, Oct. 19, 2021 ...
Entourage Health Reports Q2 Financial Results with $13.8 Million Record Revenue Representing 92% YOY Increase and Third Consecutive Quarter of Growth
10 août 2021 07h05 HE
|
Entourage Health Corp.
Continued record sales of higher-margin products in all channels drives 29% gross marginFulfilled record purchase orders from every province, focusing on top-performing products resulting in a 159%...
Entourage Health Announces Preliminary Record Q2 Revenues of $13.6 Million and Confirms Financial Results Call to be Held on August 10, 2021 at 10 a.m. ET
20 juil. 2021 08h05 HE
|
Entourage Health Corp.
TORONTO, July 20, 2021 (GLOBE NEWSWIRE) -- Entourage Health Corp. (formerly WeedMD Inc.) (TSX-V:ENTG) (OTCQX:WDDMF) (FSE:4WE) (“Entourage” or the “Company”), is pleased to announce preliminary...
WeedMD Reports First Quarter 2021 Financial Results with 102% Record Increase in Sequential Net Revenue Growth
29 juin 2021 07h15 HE
|
WeedMD Rx Inc.
Total revenue (before excise duties) of $12.9 million in Q1 2021, represents over 7% favourability over the $12.0 million Q1 2021 guidance previously providedNet revenue of $10.3 million in Q1 2021,...
WeedMD Reports Fiscal Year 2020 Financial Results and First Quarter 2021 Preliminary Gross Revenue of $12 Million
31 mai 2021 07h24 HE
|
WeedMD Rx Inc.
Net revenue increased 41% YOY to $29.4 million for the full year ended December 31, 2020Kilograms harvested in 2020 grew 88% over prior year to 33,751 with more Grade A flowerWeighted average cost per...
WeedMD to Host Fiscal Year End 2020 Conference Call on May 31st
21 mai 2021 08h18 HE
|
WeedMD Rx Inc.
Company financials to be filed after market on May 28, 2021 and operational outlook to be provided during call, including first quarter 2021 record milestones achieved TORONTO, May 21, 2021 (GLOBE...
WeedMD Inc. Granted Management Cease Trade Order
03 mai 2021 15h46 HE
|
WeedMD Rx Inc.
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, May 03, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or...
WeedMD Announces Delayed Filing of its 2020 Annual Financial Disclosure
21 avr. 2021 09h47 HE
|
WeedMD Rx Inc.
/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, April 21, 2021 (GLOBE NEWSWIRE) -- WeedMD Inc. (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE) (“WeedMD” or...